BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38132390)

  • 1. Risk Factors for Nodal Failure in Patients with FIGO IIIC Cervical Cancer Receiving Definitive Image-Guided Radiotherapy.
    Liu X; Hou X; Hu K; Zhang F; Wang W; Ren K
    Curr Oncol; 2023 Dec; 30(12):10385-10395. PubMed ID: 38132390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
    Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
    Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of the presence of pelvic and/or para-aortic lymph node metastases in cervical cancer patients; the influence of the new FIGO classification (stage IIIC).
    van Kol KGG; Ebisch RMF; van der Aa M; Wenzel HB; Piek JMJ; Bekkers RLM
    Gynecol Oncol; 2023 Apr; 171():9-14. PubMed ID: 36804623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.
    Rotman M; Pajak TF; Choi K; Clery M; Marcial V; Grigsby PW; Cooper J; John M
    JAMA; 1995 Aug; 274(5):387-93. PubMed ID: 7616634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.
    Brockbank E; Kokka F; Bryant A; Pomel C; Reynolds K
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008217. PubMed ID: 23543561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.
    Brockbank E; Kokka F; Bryant A; Pomel C; Reynolds K
    Cochrane Database Syst Rev; 2011 Apr; (4):CD008217. PubMed ID: 21491407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-field radiotherapy for locally advanced cervical cancer.
    Thamronganantasakul K; Supakalin N; Kietpeerakool C; Pattanittum P; Lumbiganon P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012301. PubMed ID: 30362204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with
    Lin AJ; Wright JD; Dehdashti F; Siegel BA; Markovina S; Schwarz J; Thaker PH; Mutch DG; Powell MA; Grigsby PW
    Int J Gynecol Cancer; 2019 Nov; 29(9):1351-1354. PubMed ID: 31473660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer.
    Ayhan A; Aslan K; Öz M; Tohma YA; Kuşçu E; Meydanli MM
    Arch Gynecol Obstet; 2019 Sep; 300(3):675-682. PubMed ID: 31263988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
    Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
    Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysis.
    Peters M; de Leeuw AAC; Nomden CN; Tanderup K; Kirchheiner K; Lindegaard JC; Kirisits C; Haie-Meder C; Sturdza A; Fokdal L; Mahantshetty U; Hoskin P; Segedin B; Bruheim K; Rai B; Huang F; Cooper R; van der Steen-Banasik E; van Limbergen E; Pieters BR; Tan LT; van Rossum PSN; Nesvacil N; Nout R; Schmid MP; Pötter R; Jürgenliemk-Schulz IM;
    Radiother Oncol; 2021 Oct; 163():150-158. PubMed ID: 34480958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodal distribution and its significance in FIGO stage IIIc endometrial cancer.
    McMeekin DS; Lashbrook D; Gold M; Scribner DR; Kamelle S; Tillmanns TD; Mannel R
    Gynecol Oncol; 2001 Aug; 82(2):375-9. PubMed ID: 11531298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant Chemotherapy in Locally Advanced Cervical Carcinoma - a Role in Patients with Para-aortic Lymph Node Involvement? A 10-year Institutional Experience.
    Green HM; Counsell N; Ward A; McCormack M
    Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):e281-e290. PubMed ID: 35000828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage IIICp cervical cancer.
    Bogani G; Vinti D; Murgia F; Chiappa V; Leone Roberti Maggiore U; Martinelli F; Ditto A; Raspagliesi F
    Int J Gynecol Cancer; 2019 Nov; 29(9):1355-1360. PubMed ID: 31422352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Risk Factor for Para-Aortic Lymph Node Recurrence After Definite Pelvic Radiotherapy in Stage IIIB Cervical Cancer.
    Zhang G; Wang C; Ma C; Miao L; He F; Fu C
    Technol Cancer Res Treat; 2022; 21():15330338221141541. PubMed ID: 36426576
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic response of pelvic and para-aortic lymph nodes during radiotherapy for carcinoma of the uterine cervix: using positron emission tomography/computed tomography.
    Yoon MS; Nam TK; Chung WK; Jeong SY; Ahn SJ; Nah BS; Song JY; Jeong JU
    Int J Gynecol Cancer; 2011 May; 21(4):699-705. PubMed ID: 21546872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review.
    Qin F; Pang H; Yu T; Luo Y; Dong Y
    Technol Cancer Res Treat; 2022; 21():15330338221086403. PubMed ID: 35341413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy.
    Chargari C; Mazeron R; Dunant A; Gouy S; Petit C; Maroun P; Uzan C; Annede P; Bentivegna E; Balleyguier C; Genestie C; Pautier P; Leary A; Lhomme C; Deutsch E; Morice P; Haie-Meder C
    Clin Exp Metastasis; 2016 Dec; 33(8):775-785. PubMed ID: 27530648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.